The deadliest diseases in the U.S. are becoming less deadly—but no one knows why

Cancer, heart disease, dementia—the deadliest of all deadly diseases. They kill millions of people every year in the U.S., but those death rates are still far smaller than the rates for the same diseases only decades ago, according to multiple surveys.

An article in the New York Times called this phenomenon “a medical mystery of the best sort,” because no one knows exactly why or how these diseases are slowly releasing their strangleholds on the American healthcare system and its patients.

For example, every 10 years since 1977 has seen a 20 percent reduction in dementia-related deaths. Deaths from heart disease are 60 percent down from their high 50 years ago.

Advanced screening, dropping smoking rates and new innovations in treatment can explain a lot of the improvements, but these factors don't explain the total decline, experts told the New York Times. And no one knows what those other factors are.

Check out the New York Times for the whole story, including theories about cellular changes that could be causing these surprising trends. 

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”